Raffa Wealth Management’s Trillium Therapeutics Inc. TRIL Stock Holding History

Raffa Wealth Management’s Portfolio TRIL Stock Details TRIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-100	Closed	-$1.76K	–	1152
2021 Q3	$1.76K	Buy	+100	New	+$1.17K	﹤0.01%	657

Other funds holding TRIL

Optiver Holding Amsterdam, Netherlands $371B AUM 64.6% 1-Year Est. Return

Raffa Wealth Management's TRIL Position: Q4 2021 in Review

Raffa Wealth Management sold out of Trillium Therapeutics Inc. (TRIL) in Q4 2021, closing a stake of 100 shares — an estimated $1.76K sold.

Raffa Wealth Management first reported a position in TRIL in Q3 2021 and held it in 1 quarter. The position peaked at $1.76K in Q3 2021. 2 funds tracked by Wall St. Rank hold TRIL as of Q4 2021.

Raffa Wealth Management reported no remaining Trillium Therapeutics Inc. position as of Q4 2021 after selling out during the quarter.
Raffa Wealth Management sold 100 Trillium Therapeutics Inc. shares in Q4 2021, an estimated $1.76K.
Raffa Wealth Management first reported a position in Trillium Therapeutics Inc. in Q3 2021 and held it in 1 quarter.
Raffa Wealth Management's Trillium Therapeutics Inc. position peaked at $1.76K in Q3 2021.
2 funds tracked by Wall St. Rank held Trillium Therapeutics Inc. as of Q4 2021.

Based on Raffa Wealth Management's 13F filing for Q4 2021, filed 27 Jul 2026.